Foreign-invested pharmaceutical firms threaten to file a complaint against price cut soon

Several pharmaceutical firms including some multinational companies, are scheduled to lodge their complaints, via leading patent & law firms, against the proposed cutback of drug prices under the previous actually transacted minimum price system.

Contending the hardest damage from the price cut, these foreign-invested pharmaceutical firms expressed their intention to lodge a complaint agains...